Recipient evaluation before BMT in South Korea costs from $3,800 to $5,900. The total price depends on the specific blood tests, imaging protocols, and clinic tier. In the US, this evaluation costs about $7,900 on average. South Korea offers savings of around 38%. The evaluation includes cardiac, respiratory, and organ function assessments in major medical hubs like Seoul.
- Hospital tier: Top facilities in Seoul often charge higher rates for specialized diagnostic equipment.
- Testing depth: Extensive HLA typing or rare antibody screens can increase the total cost.
- Consultation fees: Initial meetings with transplant specialists typically add 10-15% to the base price.
- City variations: Prices in Seoul tend to be higher than in regional medical centers.
Bookimed Expert Insight: Choosing a nationally funded facility like Seoul National University Hospital helps patients access massive clinical databases. This hospital treats about 10,700 patients daily and holds the highest cancer treatment statistics nationwide. Such volume allows clinics to maintain next-generation diagnostic tools that provide superior accuracy for transplant planning. This high-density medical environment allows for faster results compared to smaller regional centers.